# Redmile Group's Biotech Investments: 57 Startups in Its Portfolio (2026) > The 57 Biotech startups Redmile Group has backed, by stage: $13B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/redmile-group-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 19 - [Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines) - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics) - [ElevateBio](https://millionrounds.com/company/elevatebio) - [*A* Atreca](https://millionrounds.com/company/atreca) - [Science 37](https://millionrounds.com/company/science-37) - [IGM Biosciences](https://millionrounds.com/company/igm-biosciences) - [Lycia Therapeutics](https://millionrounds.com/company/lycia-therapeutics) - [ArcherDX](https://millionrounds.com/company/archerdx) - [Boundless Bio](https://millionrounds.com/company/boundless-bio) - [MedAvail](https://millionrounds.com/company/medavail) - [Deciphera Pharmaceuticals](https://millionrounds.com/company/deciphera-pharmaceuticals) - [Escient Pharmaceuticals](https://millionrounds.com/company/escient-pharmaceuticals) - [*N* NightstaRx](https://millionrounds.com/company/nightstarx) - [Genalyte](https://millionrounds.com/company/genalyte) - [Attovia Therapeutics](https://millionrounds.com/company/attovia-therapeutics) - [Ceribell](https://millionrounds.com/company/ceribell) - [Nightstar Therapeutics](https://millionrounds.com/company/nightstar-therapeutics) - [OncoResponse](https://millionrounds.com/company/oncoresponse) ## Series B 17 - [*B* BioNTech](https://millionrounds.com/company/biontech) - [Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences) - [Pliant Therapeutics](https://millionrounds.com/company/pliant-therapeutics) - [Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics) - [Strand Therapeutics](https://millionrounds.com/company/strand-therapeutics) - [Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics) - [Repare Therapeutics](https://millionrounds.com/company/repare-therapeutics) - [Annexon Biosciences](https://millionrounds.com/company/annexon-biosciences) - [Achilles Therapeutics](https://millionrounds.com/company/achilles-therapeutics) - [Syros Pharmaceuticals](https://millionrounds.com/company/syros-pharmaceuticals) - [AlloVir](https://millionrounds.com/company/allovir) - [GRO Biosciences](https://millionrounds.com/company/gro-biosciences) - [*R* Replimune](https://millionrounds.com/company/replimune) - [Zentera Therapeutics](https://millionrounds.com/company/zentera-therapeutics) - [Atara Biotherapeutics](https://millionrounds.com/company/atara-biotherapeutics) - [*AP* Ayala Pharmaceuticals](https://millionrounds.com/company/ayala-pharmaceuticals) - [Scioderm](https://millionrounds.com/company/scioderm) ## Stage not reported 15 - [Oruka Therapeutics](https://millionrounds.com/company/oruka-therapeutics) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Rapt Therapeutics](https://millionrounds.com/company/rapt-therapeutics) - [Cabaletta Bio](https://millionrounds.com/company/cabaletta-bio) - [True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics) - [Replimune Group](https://millionrounds.com/company/replimune-group) - [Invivyd](https://millionrounds.com/company/invivyd) - [Entrada Therapeutics](https://millionrounds.com/company/entrada-therapeutics) - [Bambusa Therapeutics](https://millionrounds.com/company/bambusa-therapeutics) - [Quantum SI](https://millionrounds.com/company/quantum-si) - [Virta Health](https://millionrounds.com/company/virta-health) - [Gritstone bio](https://millionrounds.com/company/gritstone-bio) - [Hookipa Pharma](https://millionrounds.com/company/hookipa-pharma) - [Prime Medicine](https://millionrounds.com/company/prime-medicine) - [One Biosciences](https://millionrounds.com/company/one-biosciences) ## Series A 6 - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [Neurogene](https://millionrounds.com/company/neurogene) - [Redx Pharma](https://millionrounds.com/company/redx-pharma) - [Mnemo Therapeutics](https://millionrounds.com/company/mnemo-therapeutics) - [*A* Attenua](https://millionrounds.com/company/attenua) - [LifeSprout](https://millionrounds.com/company/lifesprout) ## Segment by segment ### Series C and later 19 startups · $5.5B raised - [**Blueprint Medicines**](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. United States $1.4B - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**ADC Therapeutics**](https://millionrounds.com/company/adc-therapeutics) ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. Switzerland $646M - [**ElevateBio**](https://millionrounds.com/company/elevatebio) ElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017. United States $551M - [*A* **Atreca**](https://millionrounds.com/company/atreca) Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. United States $313M - [**Science 37**](https://millionrounds.com/company/science-37) Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers. United States $236M - [**IGM Biosciences**](https://millionrounds.com/company/igm-biosciences) IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer. United States $209M - [**Lycia Therapeutics**](https://millionrounds.com/company/lycia-therapeutics) Lycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California. United States $182M ### Series B 17 startups · $3.5B raised - [*B* **BioNTech**](https://millionrounds.com/company/biontech) Germany $687M - [**Wave Life Sciences**](https://millionrounds.com/company/wave-life-sciences) Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States $434M - [**Pliant Therapeutics**](https://millionrounds.com/company/pliant-therapeutics) Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases. United States $350M - [**Beam Therapeutics**](https://millionrounds.com/company/beam-therapeutics) Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology. United States $322M - [**Strand Therapeutics**](https://millionrounds.com/company/strand-therapeutics) Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments. United States $267M - [**Stoke Therapeutics**](https://millionrounds.com/company/stoke-therapeutics) Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment. United States $255M - [**Repare Therapeutics**](https://millionrounds.com/company/repare-therapeutics) Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. Canada $252M - [**Annexon Biosciences**](https://millionrounds.com/company/annexon-biosciences) Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders. United States $180M ### Stage not reported 15 startups · $2.3B raised - [**Oruka Therapeutics**](https://millionrounds.com/company/oruka-therapeutics) Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases. United States $880M - [**Nurix Therapeutics**](https://millionrounds.com/company/nurix-therapeutics) Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs. United States $250M - [**Rapt Therapeutics**](https://millionrounds.com/company/rapt-therapeutics) Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer. United States $250M - [**Cabaletta Bio**](https://millionrounds.com/company/cabaletta-bio) Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases. United States $200M - [**True North Therapeutics**](https://millionrounds.com/company/true-north-therapeutics) True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases. United States $142M - [**Replimune Group**](https://millionrounds.com/company/replimune-group) Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer. United States $140M - [**Invivyd**](https://millionrounds.com/company/invivyd) Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections. United States $125M - [**Entrada Therapeutics**](https://millionrounds.com/company/entrada-therapeutics) Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases. United States $100M ### Series A 6 startups · $1.2B raised - [**Nuvation Bio**](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. United States $675M - [**Neurogene**](https://millionrounds.com/company/neurogene) Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders. United States $194M - [**Redx Pharma**](https://millionrounds.com/company/redx-pharma) Redx Pharma is a drug discovery and development company. United Kingdom $127M - [**Mnemo Therapeutics**](https://millionrounds.com/company/mnemo-therapeutics) Mnemo Therapeutics is a biotechnology company based in Paris, founded in 2019. France $90M - [*A* **Attenua**](https://millionrounds.com/company/attenua) United States $35M - [**LifeSprout**](https://millionrounds.com/company/lifesprout) LifeSprout offers revolutionary products for soft tissue replacement and regeneration United States $35M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Redmile Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Redmile Group portfolio map** 75 startups · $14B](https://millionrounds.com/portfolio-maps/redmile-group-portfolio-map)[Co-investors **Who invests with Redmile Group** 58 co-investors](https://millionrounds.com/portfolio-maps/redmile-group-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio) ## Raising from investors like Redmile Group? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)